Quercetin may reduce the risk of developing the symptoms of COVID-19
- PMID: 38966631
- PMCID: PMC11221767
- DOI: 10.22038/AJP.2023.22920
Quercetin may reduce the risk of developing the symptoms of COVID-19
Abstract
Objective: Recent evidence reported that some dietary compounds like quercetin and apigenin as the most well-known flavonoids with anti-inflammatory effects may inhibit SARS-CoV-2 main protease. The hypothesis of the promising effects and possible mechanisms of action of quercetin against COVID-19 were assessed in this article.
Materials and methods: Related papers on the inhibitory effects of quercetin against COVID-19 were collected using the following search strategy: "corona or coronavirus or COVID or COVID-19 or viral or virus" AND "nutrient or flavonoid or Quercetin".
Results: The findings indicated that quercetin can be considered an effective agent against COVID-19 because of its SARS-CoV-2 main protease and RNA-dependent RNA polymerase inhibitory effects. In addition, quercetin may attenuate angiotensin-converting enzyme-2 (ACE-2) receptors leading to a reduction of SARS-CoV-2 ability to enter host cells. Moreover, the antiviral, anti-inflammatory, and immunomodulatory activities of quercetin have been frequently reported.
Conclusion: Quercetin may be an effective agent for managing the complications of COVID-19. Further longitudinal human studies are warranted.
Keywords: ACE-2 receptors; COVID-19; Quercetin; RNA-dependent RNA polymerase; SARS-CoV-2 main protease.
Conflict of interest statement
The authors have declared that there is no conflict of interest.
Figures
Similar articles
-
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130. Curr Pharm Des. 2021. PMID: 34225607 Review.
-
Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2.Beni Suef Univ J Basic Appl Sci. 2021;10(1):21. doi: 10.1186/s43088-021-00107-w. Epub 2021 Mar 24. Beni Suef Univ J Basic Appl Sci. 2021. PMID: 33782651 Free PMC article. Review.
-
Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies.J Biomol Struct Dyn. 2022 Oct;40(17):7656-7665. doi: 10.1080/07391102.2021.1900919. Epub 2021 Mar 22. J Biomol Struct Dyn. 2022. PMID: 33749547
-
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases.Phytomed Plus. 2023 Feb;3(1):100402. doi: 10.1016/j.phyplu.2022.100402. Epub 2022 Dec 30. Phytomed Plus. 2023. PMID: 36597465 Free PMC article. Review.
-
COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?Aging (Albany NY). 2020 Mar 30;12(8):6511-6517. doi: 10.18632/aging.103001. Epub 2020 Mar 30. Aging (Albany NY). 2020. PMID: 32229706 Free PMC article.
References
-
- Aliabadi F, Ajami M, Pazoki–Toroudi H. Why does COVID‐19 pathology have several clinical forms? Bioessays. 2020;42:e2000198. - PubMed
-
- Almeida AF, Borge GIA, Piskula M, Tudose A, Tudoreanu L, Valentová K, Williamson G, Santos CN. Bioavailability of quercetin in humans with a focus on interindividual variation. Compr Rev Food Sci Food Saf. 2018;17:714–731. - PubMed
-
- Álvarez P, Alvarado C, Puerto M, Schlumberger A, Jiménez L, De la Fuente M. Improvement of leukocyte functions in prematurely aging mice after five weeks of diet supplementation with polyphenol-rich cereals. Nutrition. 2006;22:913–921. - PubMed
-
- Bachmetov L, Gal‐Tanamy M, Shapira A, Vorobeychik M, Giterman‐Galam T, Sathiyamoorthy P, Golan‐Goldhirsh A, Benhar I, Tur‐Kaspa R, Zemel R. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J Viral Hepat. 2012;19:81–88. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous